Pulished Date October, 2018
ID: 7881
Share on
Share on

Asia Pacific PDE Inhibitors Market by Application (Erectile Dysfunction, Cardiovascular Diseases, Benign Prostate Hyperplasia, Respiratory Diseases, Neurological Diseases, Dermatological Disorders, Pulmonary Hypertension, Others), by Drug Class (PDE-1, PDE-2, PDE-3, PDE-4, PDE-5, Viagra, Cialis, Levitra, Others), by Region - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2018-2023)

Pulished: October, 2018
ID: 7881
Pages: 145

Asia Pacific PDE Inhibitors market size was approximately USD XX million in 2018 and showing a huge increase with a CAGR of XX% and is anticipated to reach USD XX million by 2023.

The high sales and market growth of PDE-5 have encouraged pharmaceutical manufacturers to invest more money in further research of PDE Inhibitors market. This is expected to be a key driving factor of the market. Increasing awareness of people towards usage of PDE Inhibitors is propelling the market size. 

The PDE Inhibitors market is segmented by Application and by Drug Type. By Application, the market is categorized into Erectile Dysfunction, Cardiovascular Diseases, Benign Prostate Hyperplasia, Respiratory Diseases, Neurological Diseases, Dermatological Disorders, Pulmonary Hypertension, Others. By Drug type, the market is further divided into PDE-1, PDE-2, PDE-3, PDE-4, PDE-5, Viagra, Cialis, Levitra, and others. The increasing demand for PDE-5 from the pediatric patients suffering from Pulmonary Hypertension has helped it to occupy the major market share. Besides, PDE-5 can also be used to treat patients suffering from erectile dysfunction and minor heart attacks, this can further fuel the market size. From the recent studies, we can easily conclude that PDE-5 can be safely suggested to infants and children suffering from Pulmonary Hypertension which can also be attributed to increasing the size of the PDE Inhibitors market. The PDE-4 inhibitor which is used in treating atopic dermatitis and skin disorders is also expected to increase its demand as some of its key manufacturers received FDA approval regarding its production.

By geography, the market is segmented into India, China, Japan, South Korea, and others. In developing countries like India and China, the market is showing a considerable rise in the past few years and looking forward to increasing furthermore in coming years.

Some of the major manufacturers in the PDE Inhibitors Market are Mist Pharmaceuticals, AstraZeneca, Nusirt Biopharma, Takeda Pharmaceuticals, Bayer AG, Pfizer, Otsuka, Eli Lilly, Verona Pharma, Omeros, Hanmi Science Holding, Celgene Corporation.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Pulmonary Hypertension  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Benign Prostate Hyperplasia           

                                5.1.5 Respiratory Diseases          

                                5.1.6 Neurological Diseases        

                                5.1.7 Dermatological Disorders  

                                5.1.8 Erectile Dysfunction            

                                5.1.9 Other Applications               

                                5.1.10  Y-o-Y Growth Analysis, By Application     

                                5.1.11  Market Attractiveness Analysis, By Application   

                                5.1.12  Market Share Analysis, By Application     

                5.2 Drug Type                   

                                5.2.1 Introduction           

                                5.2.2 Selective PDE inhibitors     

                                                5.2.2.1 PDE-1

                                                5.2.2.2 PDE-2

                                                5.2.2.3 PDE-3

                                                5.2.2.4 PDE-4

                                                5.2.2.5 PDE-5

                                                5.2.2.6 Others ( PDE-6 to PDE-11 )

                                5.2.3 Non-selective PDE inhibitors           

                                                5.2.3.1 Viagra

                                                5.2.3.2 Cialis

                                                5.2.3.3 Levitra

                                                5.2.3.4 Other Drugs

                                5.2.4 Y-o-Y Growth Analysis, By Drug Type           

                                5.2.5 Market Attractiveness Analysis, By Drug Type         

                                5.2.6 Market Share Analysis, By Drug Type          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Drug Type

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Drug Type

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Drug Type

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Mist Pharmaceuticals                             

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 AstraZeneca                               

                8.3 Nusirt Biopharma                     

                8.4 Takeda Pharmaceuticals                       

                8.5 Bayer AG                     

                8.6 Pfizer                            

                8.7 Otsuka                          

                8.8 Eli Lilly                           

                8.9 Verona Pharma                        

                8.10 Omeros                     

                8.11  Hanmi Science Holding                       

                8.12 Celgene Corporation                            

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Matrix, by  Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Asia Pacific PDE Inhibitors Market By Application, From 2018-2023 ( USD Million )
  2. Asia Pacific Erectile Dysfunction Market By Region, From 2018-2023 ( USD Million )
  3. Asia Pacific Cardiovascular Diseases Market By Region, From 2018-2023 ( USD Million )
  4. Asia Pacific Benign Prostate Hyperplasia Market By Region, From 2018-2023 ( USD Million )
  5. Asia Pacific Respiratory Diseases Market By Region, From 2018-2023 ( USD Million )
  6. Asia Pacific Neurological Diseases Market By Region, From 2018-2023 ( USD Million )
  7. Asia Pacific Dermatological Disorders Market By Region, From 2018-2023 ( USD Million )
  8. Asia Pacific Pulmonary Hypertension Market By Region, From 2018-2023 ( USD Million )
  9. Asia Pacific Other Applications Market By Region, From 2018-2023 ( USD Million )
  10. Asia Pacific PDE Inhibitors Market By Drug Class, From 2018-2023 ( USD Million )
  11. Asia Pacific PDE-1 Market By Region, From 2018-2023 ( USD Million )
  12. Asia Pacific PDE-2 Market By Region, From 2018-2023 ( USD Million )
  13. Asia Pacific PDE-3 Market By Region, From 2018-2023 ( USD Million )
  14. Asia Pacific PDE-4 Market By Region, From 2018-2023 ( USD Million )
  15. Asia Pacific PDE-5 Market By Region, From 2018-2023 ( USD Million )
  16. Asia Pacific Viagra Market By Region, From 2018-2023 ( USD Million )
  17. Asia Pacific Cialis Market By Region, From 2018-2023 ( USD Million )
  18. Asia Pacific Levitra Market By Region, From 2018-2023 ( USD Million )
  19. Asia Pacific Other Drugs Market By Region, From 2018-2023 ( USD Million )
  20. Japan PDE Inhibitors Market By Application, From 2018-2023 ( USD Million )
  21. Japan PDE Inhibitors Market By Drug Class, From 2018-2023 ( USD Million )
  22. China PDE Inhibitors Market By Application, From 2018-2023 ( USD Million )
  23. China PDE Inhibitors Market By Drug Class, From 2018-2023 ( USD Million )
  24. India PDE Inhibitors Market By Application, From 2018-2023 ( USD Million )
  25. India PDE Inhibitors Market By Drug Class, From 2018-2023 ( USD Million )
  26. Australia PDE Inhibitors Market By Application, From 2018-2023 ( USD Million )
  27. Australia PDE Inhibitors Market By Drug Class, From 2018-2023 ( USD Million )
  28. South Korea PDE Inhibitors Market By Application, From 2018-2023 ( USD Million )
  29. South Korea PDE Inhibitors Market By Drug Class, From 2018-2023 ( USD Million )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Request Sample